4.1 Article

Cariprazine for treating psychosis: an updated meta-analysis

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial

Suresh Durgam et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2016)

Article Pharmacology & Pharmacy

CARIPRAZINE: NEW DOPAMINE BIASED AGONIST FOR NEUROPSYCHIATRIC DISORDERS

P. De Deurwaerdere

DRUGS OF TODAY (2016)

Article Psychology, Clinical

Etiologic, Phenomenologic, and Endophenotypic Overlap of Schizophrenia and Bipolar Disorder

Godfrey D. Pearlson

ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 11 (2015)

Article Pharmacology & Pharmacy

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia Results From an International, Phase III Clinical Trial

John M. Kane et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)

Review Pharmacology & Pharmacy

Dopamine D3 receptor as a new pharmacological target for the treatment of depression

Gian Marco Leggio et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2013)